SEC 13F Intelligence

Managers / Q1 2020 · view latest →

Centerbridge Partners, L.P.

CIK 0001484836 · 375 PARK AVENUE, 11TH FLOOR, NEW YORK, NY, 10152 · 212 672 5000

Reported Value
$412M
Q1 2020
Positions
40
Filings on Record
33
2019–present window
Filed
May 15, 2020
original filing

Summary

Centerbridge Partners, L.P. reported $412M in U.S.-listed holdings across 40 positions for Q1 2020.

The portfolio is heavily concentrated: American Renal Assocs alone accounts for 28.2% of reported value.

Compared with Q4 2019, the fund opened 9 new positions and exited 1.

Portfolio Metrics

Turnover
+11.1%
vs prior filed quarter
Top-10 Concentration
+89.7%
share of reported value
Largest Position
+28.2%
American Renal Assocs
New / Exited
9 / 1
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $982MQ4 ’18Q1 ’19: $729MQ2 ’19: $815MQ3 ’19: $550MQ4 ’19: $618MQ4 ’19Q1 ’20: $412MQ2 ’20: $468MQ3 ’20: $894MQ4 ’20: $1.2BQ4 ’20Q1 ’21: $1.1BQ2 ’21: $1.1BQ3 ’21: $856MQ4 ’21: $1.8BQ4 ’21Q1 ’22: $1.6BQ2 ’22: $1.1BQ3 ’22: $875MQ4 ’22: $1.0BQ4 ’22Q1 ’23: $1.0BQ2 ’23: $642MQ3 ’23: $467MQ4 ’23: $604MQ4 ’23Q1 ’24: $623MQ2 ’24: $505MQ3 ’24: $478MQ4 ’24: $468MQ4 ’24Q1 ’25: $510MQ2 ’25: $434MQ3 ’25: $101MQ4 ’25: $59MQ4 ’25Q1 ’26: $61Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 84.4%ETP: 6.0%US DOMESTIC: 4.9%Other: 1.8%ADR: 1.5%Unit: 1.4%
  • Common Stock · 84.4% · $348M
  • ETP · 6.0% · $25M
  • US DOMESTIC · 4.9% · $20M
  • Other · 1.8% · $8M
  • ADR · 1.5% · $6M
  • Unit · 1.4% · $6M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
ISHARES TRNEW+200.0K200.0K+$25M$25M
SGRYSURGERY PARTNERS INCNEW+1.04M1.04M+$7M$7M
EXTENDED STAY AMER INCNEW+810.8K810.8K+$6M$6M
CYHCOMMUNITY HEALTH SYS INC NEWNEW+1.70M1.70M+$6M$6M
BLACKSTONE MTG TR INCNEW+6.50M6.50M+$5M$5M
UNITI GROUP INCNEW+500.0K500.0K+$3M$3M
MALLINCKRODT PUB LTD CONEW+1.17M1.17M+$2M$2M
ENDO INTL PLCNEW+600.0K600.0K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2020

14 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1AMERICAN RENAL ASSOCS HLDGSCOM28.25%$116M17.62M
2GNKGENCO SHIPPING & TRADING LTDhistory →SHS16.33%$67M10.49M
3HGVHILTON GRAND VACATIONS INChistory →COM15.68%$65M4.10M
4PCGPG&E CORPhistory →COM10.48%$43M4.81M
5ISHARES TRIBOXX INV CP ETF5.99%$25M200.0K
6FOCUS FINL PARTNERS INCCOM CL A5.03%$21M901.8K
7ENSCO JERSEY FIN LTDNOTE 3.000% 1/33.24%$13M51.33M
8SGRYSURGERY PARTNERS INChistory →COM1.64%$7M1.04M
9BLACKSTONE MTG TR INCNOTE 4.375% 5/0 · NOTE 4.750% 3/11.63%$7M8.50M
10EXTENDED STAY AMER INCUNIT 99/99/9999B1.44%$6M810.8K
11CYHCOMMUNITY HEALTH SYS INC NEWhistory →COM1.38%$6M1.70M
12MALLINCKRODT PUB LTD COSHS0.56%$2M1.17M
13ENDO INTL PLCSHS0.54%$2M600.0K
14TEVATEVA PHARMACEUTICAL INDS LTDSPONSORED ADS0.22%$898,000100.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$61M3May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$59M2Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$101M4Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$434M9Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$510M11May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$468M13Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$478M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$505M17Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$623M20May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$604M20Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$467M25Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$642M27Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$1.0B29May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$1.0B34Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$875M62Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$1.1B67Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.6B71May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.8B111Feb 17, 2022RESTATEMENTchanges · EDGAR ↗
Q3 2021$856M108Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.1B124Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.1B109May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.2B36Feb 23, 2021RESTATEMENTchanges · EDGAR ↗
Q3 2020$894M23Nov 17, 202013F-HRchanges · EDGAR ↗
Q2 2020$468M33Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$412M40May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$618M17Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$550M22Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$815M20Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$729M26May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$982M37Feb 14, 201913F-HRchanges · EDGAR ↗

Other Included Managers

This filing reports holdings on behalf of 9 additional managers.

  • Centerbridge Credit Advisors, L.L.C.028-13862
  • Centerbridge Partners Holdings, LLC028-13861
  • Aronson Jeffrey028-13858
  • Gallogly Mark T028-13857
  • Centerbridge Special Credit Advisors, L.L.C.028-14395
  • Centerbridge Advisors, LLC028-15424
  • Centerbridge Special Credit Advisors II, L.L.C028-16779
  • Centerbridge Special Credit Advisors III, L.L.C.028-19382
  • Centerbridge Advisors II, LLC028-20085

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.